Business Description
Celltrion Healthcare Co Ltd
Compare
Compare
Traded in other countries / regions
091990.Korea IPO Date
2017-07-28Description
Celltrion Healthcare Co Ltd markets, sells and distributes biosimilar and biological medicines developed by the company through extensive global network that covers more than 120 different countries, including both developed and emerging markets.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.45 | |||||
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | 1.51 | |||||
| Interest Coverage | 28.9 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.88 | |||||
| Beneish M-Score | -2.68 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 23.4 | |||||
| 3-Year EBITDA Growth Rate | 44.6 | |||||
| 3-Year EPS without NRI Growth Rate | 33.5 | |||||
| 3-Year Book Growth Rate | 5.7 | |||||
| Future 3-5Y Total Revenue Growth Rate | 15.77 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 63.14 | |||||
| 9-Day RSI | 62.56 | |||||
| 14-Day RSI | 61.2 | |||||
| 6-1 Month Momentum % | -11.46 | |||||
| 12-1 Month Momentum % | -12.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | |||||
| Quick Ratio | 0.86 | |||||
| Cash Ratio | 0.24 | |||||
| Days Inventory | 578.63 | |||||
| Days Sales Outstanding | 96.89 | |||||
| Days Payable | 281.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.2 | |||||
| Dividend Payout Ratio | 0.14 | |||||
| Forward Dividend Yield % | 0.2 | |||||
| 5-Year Yield-on-Cost % | 0.2 | |||||
| 3-Year Average Share Buyback Ratio | -1.6 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 28.48 | |||||
| Operating Margin % | 11.61 | |||||
| Net Margin % | 7.46 | |||||
| ROE % | 7.04 | |||||
| ROA % | 3.53 | |||||
| ROIC % | 6.3 | |||||
| ROC (Joel Greenblatt) % | 17.25 | |||||
| ROCE % | 10.53 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 69.09 | |||||
| Forward PE Ratio | 31.95 | |||||
| PE Ratio without NRI | 66.77 | |||||
| Price-to-Owner-Earnings | 138.25 | |||||
| PEG Ratio | 2.59 | |||||
| PS Ratio | 5.11 | |||||
| PB Ratio | 5.12 | |||||
| Price-to-Tangible-Book | 5.16 | |||||
| Price-to-Free-Cash-Flow | 49.38 | |||||
| Price-to-Operating-Cash-Flow | 48.93 | |||||
| EV-to-EBIT | 41.96 | |||||
| EV-to-Forward-EBIT | 23.11 | |||||
| EV-to-EBITDA | 41.05 | |||||
| EV-to-Forward-EBITDA | 22.89 | |||||
| EV-to-Revenue | 5.05 | |||||
| EV-to-Forward-Revenue | 4.28 | |||||
| EV-to-FCF | 48.05 | |||||
| Price-to-Projected-FCF | 15.54 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.76 | |||||
| Price-to-Graham-Number | 3.98 | |||||
| Price-to-Net-Current-Asset-Value | 5.61 | |||||
| Earnings Yield (Greenblatt) % | 2.39 | |||||
| Forward Rate of Return (Yacktman) % | 19.09 |
How Celltrion Healthcare Co Ltd (XKRX:091990) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Celltrion Healthcare Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 1,972,188.077 | ||
| EPS (TTM) (â‚©) | 948.039 | ||
| Beta | 0.55 | ||
| Volatility % | 19.2 | ||
| 14-Day RSI | 61.2 | ||
| 14-Day ATR (â‚©) | 2683.470784 | ||
| 20-Day SMA (â‚©) | 61460 | ||
| 12-1 Month Momentum % | -12.01 | ||
| 52-Week Range (â‚©) | 51730.76923 - 76826.923076 | ||
| Shares Outstanding (Mil) | 154.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Celltrion Healthcare Co Ltd Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Celltrion Healthcare Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Celltrion Healthcare Co Ltd Frequently Asked Questions
What is Celltrion Healthcare Co Ltd(XKRX:091990)'s stock price today?
The current price of XKRX:091990 is â‚©65500.00. The 52 week high of XKRX:091990 is â‚©76826.92 and 52 week low is â‚©51730.77.
When is next earnings date of Celltrion Healthcare Co Ltd(XKRX:091990)?
The next earnings date of Celltrion Healthcare Co Ltd(XKRX:091990) is .
Does Celltrion Healthcare Co Ltd(XKRX:091990) pay dividends? If so, how much?
The Dividend Yield %  of Celltrion Healthcare Co Ltd(XKRX:091990) is 0.2% (As of Today), Highest Dividend Payout Ratio of Celltrion Healthcare Co Ltd(XKRX:091990) was 0.27. The lowest was 0.14. And the median was 0.2. The  Forward Dividend Yield % of Celltrion Healthcare Co Ltd(XKRX:091990) is 0.2%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
